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Muscarinic-cholinergic antagonism produces learning and 
memory deficits in a wide variety of hippocampal-dependent 
tasks. Hippocampal lesions produce both acquisition deficits 
and retrograde amnesia of contextual fear (fear of the place 
of conditioning), but do not impact fear conditioning to 
discrete cues (such as a tone). In order to examine the effects 
of muscarinic antagonism in this paradigm, rats were given 
0.01 to 100 mg/kg of scopolamine (or methylscopolamine) 
either before or after a fear conditioning session in which 
tones were paired with aversive footshocks. Fear to the 
context and the tone were assessed by measuring freezing in 
separate tests. It was found that pretraining, but not post-
training, scopolamine severely impaired fear conditioning; 
methylscopolamine was ineffective in disrupting 
conditioning. Although contextual fear conditioning was 
more sensitive to cholinergic disruption, high doses of 
scopolamine also disrupted tone conditioning. Scopolamine 
did not affect footshock reactivity, but did produce high 
levels of activity. However, hyperactivity was not directly 
responsible for deficits in conditioning. It was concluded 
that scopolamine disrupts CS-US association formation or 
CS processing, perhaps through an attenuation of 
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Cholinergic neurotransmission is known to be essential
for many forms of learning. Using muscarinic receptor
antagonists (scopolamine or atropine), pervasive im-
pairments of learning have been demonstrated in hu-
mans (Crow and Grove-White 1973), monkeys (Aigner
et al. 1991), rabbits (Harvey et al. 1983, and rodents
(Levin et al. 1990). In many behavioral paradigms, the
deficits produced by muscarinic-cholinergic antago-
nism are similar to the effects produced by hippocam-
pal lesions (Watts et al. 1981; Anagnostaras et al. 1995),
while in others they are more general (Hagan et al.
1986; Rudy 1996; Paylor and Rudy 1990). Although the
precise mechanism for muscarinic antagonistic effects
on memory is unknown, it may involve the disruption
of hippocampal theta rhythm, which is normally acti-
vated during exploratory behavior (Vanderwolf et al.
1978), and the attenuation of hippocampal long-term
potentiation (LTP) (Huerta and Lisman 1995).
Recent studies indicate that the hippocampus has an
important role in Pavlovian fear conditioning. During
fear conditioning, a discrete conditional stimulus (CS;
often a tone) is paired with an aversive unconditional
stimulus (US; often an electrical footshock) in a novel
context. With repeated pairings, the animal learns to
fear both the tone and the training context. Hippocam-
pal lesions produce an acquisition deficit (Phillips and
LeDoux 1992; Maren and Fanselow 1997) and a time-
limited retrograde amnesia (Kim and Fanselow 1992;
Anagnostaras et al. 1999) that is selective for contextual
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fear. The acquisition of contextual fear also seems to de-
pend on the induction of hippocampal LTP, as NMDA
receptor blockade prior to, but not after, conditioning
disrupts the acquisition of contextual fear (Kim et al.
1991; Fanselow et al. 1994; Young et al. 1994; Maren et
al. 1996b). Moreover, there is a high correspondence be-
tween hippocampal theta rhythm and the acquisition of
contextual fear (Maren et al. 1994a). Thus, because the
hippocampus receives intensive cholinergic input from
the medial septal nucleus (Amaral and Kurz 1985), one
would expect that muscarinic-cholinergic antagonism
should disrupt contextual fear acquisition, at least to
the extent that anticholinergic action can attenuate hip-
pocampal function.
Consistent with this view, we recently reported a
large, but selective deficit in contextual fear condition-
ing when 1 mg/kg of scopolamine was administered
prior to conditioning (Anagnostaras et al. 1995). Tone
fear conditioning, which is typically intact in animals
with hippocampal dysfunction (Kim and Fanselow
1992; Phillips and LeDoux 1992), but readily disrupted
by manipulations directed at the amygdala (Maren et
al. 1996a; Davis 1986), was mildly but nonsignificantly
impaired (Anagnostaras et al. 1995). Because the
amygdala receives cholinergic innervation from the nu-
cleus basalis magnocellularis a milder amygdala im-
pairment may have been present as well. Consistent
with our findings, Rudy (1996) has found that the same
dose of scopolamine administered to juvenile rats (23-
day-old) disrupted contextual fear more than acoustic
cue fear (although acoustic cue fear was also signifi-
cantly disrupted) when given prior to conditioning.
However, Rudy also found that post-training scopol-
amine produced retrograde amnesia of contextual fear,
while we failed to observe this effect.
Based on these observations, we sought to examine
the following hypotheses: 1) both context and tone fear
conditioning may be sensitive to cholinergic disruption,
but contextual fear is more readily and more robustly
disrupted (i.e., the dose-effect curve is shifted to the
left); and 2) the very young rats Rudy used may have
exhibited retrograde amnesia from post-training scopo-
lamine either because cholinergic neurotransmission is
required for consolidation only during maturation or
because they are more sensitive to the drug. As such,
we became motivated to generate a full dose-effect
curve for the effect of pre-training scopolamine on Pav-
lovian fear conditioning and to examine the effects of
higher post-training doses in weanling and mature rats.
Moreover, we sought to more thoroughly characterize
the behavioral effects of scopolamine on Pavlovian fear
conditioning through measurements of several aspects
of conditioning. Through behavioral specification of the
pattern of deficits produced by the drug, we hope to de-








Scopolamine-HBr (scopolamine; Research Bio-
chemicals International, Natick, MA) or scopolamine
methyl-Br (methylscopolamine; Sigma Chemical Co.,
St. Louis, MO) was prepared fresh daily in cold 0.9% sa-
line and stored in a light-proof container. Unless other-
wise noted, the drugs or control saline (0 mg/kg) were
given in doses of 1 ml/kg, i.p. and the weight of the salt













consisted of aluminum (side walls) and Plexiglas (front,
back, and top) chambers (28 cm wide, 21 cm high, and
22 cm in diameter; Lafayette Instruments, Lafayette,
IN). The floor of each chamber had 18 stainless steel
rods (0.4 cm in diameter, 1.5 cm apart) connected to a
shock scrambler and generator (which, along with in-
ternal ventilation fans, supplied background noise of 70
dB/A-scale). The chambers were cleaned with 5% am-
monium hydroxide solution (in collection pans below
the rods). These computer-controlled (Med Associates
Inc., Lafayette, IN) chambers were in a well-lit room
separate from the observers, who viewed the animals
on video screens, and were blind to the experimental
conditions.
Tones were presented from a speaker in the wall of




 context was in a separate
room. These chambers (same as above) had a white rear









 to the floor forming a triangular enclo-
sure. The floors consisted of 17 staggered rods (two
rows 1 cm apart vertically; in each row, each rod 2.6 cm
apart). Background noise (70 dB) was supplied by a
white noise generator and the chambers were scented
with 1% acetic acid solution. This room was kept en-
tirely dark except for a 30 W red light bulb. The carriers
used to transport the animals to this context were also
different than before. Our previous and current experi-
ence is that animals show little generalization between
these contexts, which are differentiated on the basis of




Freezing, an established index of condi-
tional fear in the rat, was defined as the absence of any
visible movement (including the vibrissae) except that
required for respiration (only fluctuation in the volume
of the thorax). It was scored according to a blind instan-
taneous 8-sec time-sampling procedure, in which each
animal was observed eight times per 64-s interval, and
these were averaged to yield an estimate of the percent
time freezing. Prior study has revealed that this mea-
sure is highly amenable to parametric analysis (Fanse-






























Experiment 1: The Effect of Pretraining Scopolamine 
on Fear Conditioning
 
In Experiment 1, animals were given a logarithmically
varied series of doses from 0.01 to 100 mg/kg of scopol-
amine. These doses were chosen because our survey of
the literature suggested that 0.01 mg/kg was well be-
low that which has been reported to produce a learning









 3000 mg/kg; Research Biochemicals Interna-
tional, product literature), completing a logarithmic
scale which would allow us to calculate median doses
for the disruption of conditioning. No animals ap-




Ninety female Long-Evans rats (250–300 g,
90–110 days) bred at UCLA (Blue-Spruce stock; Harlan
Sprague-Dawley Inc., San Diego, CA) were used in this
experiment. They were housed in individual metal
cages located in a colony maintained on a 14:10
light:dark cycle. They had unrestricted access to dry
food and water and were handled briefly prior to test-





Fifteen min prior to conditioning, animals


















































scopolamine, i.p. They were then placed into the condi-
tioning chambers, and after a 3-min baseline period, the
animals received five tone (30 sec, 2 kHz, 85 dB/A
scale)–shock (2 sec, 1 mA) pairings, with each pairing
separated by 64 sec each. One min after the last shock,
the animals were returned to their home cages. Freez-
ing was scored continuously over the 12-min training
period.
 
Generalized Activity.  
 
In order to assess activity pro-
duced by scopolamine on the training day, horizontal
activity was assessed during the 3-min baseline period
prior to the first shock. Cage-crossovers were scored
from videotape by blind observers, and defined as full
crossing of both the fore and hind paws across the mid-
point of each cage (designated by a black vertical stripe
placed on the video monitors).
 
Activity Burst Assessment.  
 
In order to determine if
scopolamine attenuated reaction to the aversive foot-
shock, we assessed the velocity of the visible uncondi-
tional response (UR) to the first shock during condition-
ing. We have recently validated this new measure of the
UR, demonstrating that it has a highly sensitive shock
intensity function (Godsil et al. 1997).
Each animal’s response during the first 2-sec foot-
shock was digitized from videotape at 10 Hz (20
frames) with NIH Image (v. 1.6.1; National Institutes of
Health, Bethesda, MD) using the built-in digitizer on an
Apple Macintosh 8500/180 (Apple Computer Inc., Cu-
pertino, CA) and compared with the 2-sec baseline pe-
riod immediately prior to the footshock. For each
frame, a blind observer clicked on the location of the rat
and x-y coordinates were recorded by Image using the
wand auto-measure tool. This data was imported into
Microsoft Excel (Microsoft Corp., Redmond, WA) and
distance traveled between each frame in pixels was
















































]; pixels traveled was then converted into
cm traveled based on known landmarks in the picture
frame (the box dimensions).
Finally, this was divided by time and averaged over
the 2-sec period to yield the animal’s mean velocity in
cm/sec separately for the 2-sec baseline and 2-sec shock
period. Although other indexes of movement intensity
can be taken, prior work indicates that velocity has the
most sensitive shock-intensity function and is a good
predictor of later conditioning in the range of shocks we
typically use in fear conditioning (Godsil et al. 1997).
For convergent validity, we used a more traditional
measure of pain sensitivity in Experiment 3, however,
we favor UR velocity, because it is an actual measure of





In either case, for the present study both measures
yielded equivalent findings.
 
Tests for Conditioning.  
 
In order to allow for drug
clearance and the resumption of a normal sleep-wake
cycle, the animals were allowed to rest for one week.
Eight days after conditioning, all animals were placed





 Freezing behavior was scored continu-
ously. One day later the animals were brought to a





were placed in this context and after a 2-min baseline
the conditioning tone (as before) was presented for
4 min.
 
Experiment 2: The effect of Pre-Training 
Methylscopolamine on Fear Conditioning
 
In order to determine if the effects of scopolamine ob-
served in Experiment 1 were due to action in the central
nervous system, we examined the effect of pre-training
methylscopolamine, which does not cross the blood-





Thirty female Long-Evans rats (250–300 g,
90–110 days) bred at UCLA were used in this experi-





Fifteen min prior to conditioning, animals

























kg methylscopolamine, i.p. Conditioning was under the




























kg of scopolamine produced substantial impairments in




All testing was done as in Experiment 1, al-
though given the absence of any effect of scopolamine,
the UR was not examined in Experiment 2. Post-shock
freezing was also not examined, but activity during
training, and context and tone conditioning 8–9 days af-
ter training were all assessed under conditions identical
to Experiment 1.
 
Experiment 3: Scopolamine and
Shock-Intensity Thresholds
 
In order to obtain convergent validity with our novel
UR measure from Experiment 1, we employed a tradi-
tional method of examining shock sensitivity in rats. A
naive set of animals had to be used, and they were
given a series of incremental ascending shocks while
their thresholds for making a flinch, jump, or vocaliza-




Eighteen female Long-Evans rats (250–300 g,
90–110 days) bred at UCLA were used in this experi-
ment (as before).
 
Flinch-Jump-Vocalization Threshold Testing.  
 
Fifteen
min prior to testing, the animals received 0, 1, or 100








 6/dose). The animals
were then transported to the laboratory and immedi-
ately placed into conditioning chambers. Each animal
received two ascending series of 2-sec shocks in 0.05-
mA increments (beginning from 0), each shock 10 sec
apart.
A blind observer noted the first instance of a flinch
(defined as any noticeable reaction, most often a head
jerk), jump (defined as any of the animal’s paws leaving
the grid floor), or vocalization (defined as any audible
squeal) response. As soon as all three responses were
observed in a given series, the next series began at 0
mA. Shocks greater than 0.8 mA were never needed.
Two observations each for flinch, jump, and vocalize
were averaged to generate thresholds for each rat.
 
Experiment 4: The Effect of Post-Training 
Scopolamine on Fear Conditioning
 
In order to determine if a higher dose of scopolamine
than we previously used (Anagnostaras et al. 1995)
could produce retrograde amnesia in adult rats, a high
dose (10 mg/kg) was administered either immediately




Thirty male Long-Evans rats (300–400 g, 90–
110 days) bred at UCLA were used in this experiment





Conditioning was identical to Experiments
1 and 2, except for the following differences: 1) because
male rats, which condition more rapidly than female
rats (Maren et al. 1994b), were used, three instead of
five tone-shock pairings were given; and 2) the animals













imals received 10 mg/kg scopolamine, i.p., immedi-













animals received saline immediately after training and













 10)—animals were given sa-
line immediately after training and 24 hrs later. After
training, great care was taken so that all animals re-




Because animals were not on drug until after
training, activity, UR, and post-shock freezing were not
assessed during training. Eight to nine days after condi-
tioning, context and tone conditioning were assessed as
before.
 
Experiment 5: The Effect of Post-Training 
Scopolamine on Fear Conditioning in Juvenile and 
Mature Rats
 
In order to determine if post-training scopolamine
would produce retrograde amnesia in weanling rats be-
cause they may be more sensitive to the drug (e.g., Pay-
lor and Rudy 1990; Rudy 1996; Anagnostaras et al.
1995), the effect of 1 and 50 mg/kg of post-training sco-
polamine was examined in animals the same age as
those Rudy (1996) used and in mature rats. In order to
accommodate the juvenile animals, several procedural













 (70–75 days, 175-225g) female Long-
Evans rats bred at UCLA were used. The animals were
housed in groups of 2–3 (segregated by age) and had




The contexts were as before, except for the
following modifications (used for all animals): 1) the
rod floors in the training and context test context were
replaced with ones that were thinner and more tightly
spaced (24 rods, 0.2 cm in diameter, 1 cm apart); and 2)
flat Plexiglas inserts were placed into the tone test con-





After being transported to the laboratory,
the animals were placed into the conditioning cham-
bers, and after a 2-min baseline period, received three
tone (20 sec, 80-dB/A scale)–shock (2 sec, 1 mA) pair-
ings, with each pairing separated by 2 min [these pa-
rameters were taken from Rudy (1996), Experiment 5,




































 rats were divided into three sub-
























 11; mature 
 
n 5
13), or 50 (juvenile n 5 11; mature n 5 12) mg/kg sco-
polamine (2 ml/kg, i.p.) immediately after training.
Great care was taken so that all animals received injec-
tions within 2-min of the last tone-shock pairing.
Testing.  Because animals were not on drug until after
training, activity, UR, and post-shock freezing were not
assessed. Eight to nine days after conditioning, context
and tone testing were done as before.
RESULTS
Experiment 1: The Effect of Pretraining Scopolamine 
on Fear Conditioning
Generalized Activity.  As can be seen in Figure 1A,
scopolamine produced a large dose-dependent increase
in cage cross-overs during the 3-min baseline period on
the training day. A univariate analysis of variance
(ANOVA) confirmed group differences [F(5,82) 5 10.7,
p , .0001]. Relative to saline control animals, 1, 10, and
100 mg/kg of scopolamine produced significant hyper-
activity (Fischer’s protected least significant differences
(PLSD), multiple post-hoc comparisons, p , .01), but
0.01 or 0.1 mg/kg (p . .5) did not. Moderate to high
doses of the drug (1, 10, or 100 mg/kg) increased activ-
ity, on average, 30–80%.
On the other hand, Figure 1B shows the distribution
of cage crossovers (median and range). Although there
is a large increase in average activity, even at 100 mg/
kg only two out of 15 animals were outside of the range
of that of saline control animals. These findings are con-
sistent with many prior reports of hyperlocomotion in
scopolamine-treated animals (see Mathur et al. 1997 for
an analysis).
Activity Burst Velocity.  Scopolamine had virtually
no impact on the visible unconditional response to shock
at any dose (Table 1A, Experiment 1). The drug doses
did not differ in terms of activity burst velocity whether
baseline was subtracted or not [separate ANOVAs,
F(5,82) , 0.2, p . .9]. All groups exhibited a massive in-
crease in velocity during the shock [separate paired
two-tailed t-tests for each dose, baseline vs. shock: t(13–
14) . 10, p , .0001].
Post-Shock Freezing.  Figures 2A and 2B visually de-
pict the effect of scopolamine on freezing observed dur-
ing the training day, on drug. Figure 2A depicts the ac-
quisition of post-shock freezing. For baseline, freezing
during the 3-min baseline and first 30-sec tone is de-
picted. For each trial (94 sec), freezing during shock-
free period after that shock and during the next 30-s
tone prior to the next shock is depicted. Saline control
(0) animals showed evidence of acquisition of post-
shock freezing [paired two-tailed t-test, BL vs. trial 4,
t(14) 5 9.3, p , .0001)] as did animals receiving 0.01
[t(14) 5 8.8, p , .0001], 0.1 [t(13) 5 5.6, p , .0001], and 1
[t(14) 5 2.8, p 5 .01] mg/kg, whereas those receiving 10
or 100 mg/kg hardly exhibited any freezing and did
not show significant acquisition [t (13–14) , 1.8, p . .1].
Indeed, over three quarters of the animals in these two
groups did not exhibit any post-shock freezing at all.
Figure 2B depicts the average freezing observed during
training separated for periods when the tone was on
compound and for when it was not context alone. Unam-
biguous dose-dependent effects on post-shock freezing
Figure 1. Experiment 1: The effect of Pre-Training Scopol-
amine on Fear Conditioning. (A) Average Activity. During
the 3-min baseline period prior to the first shock on the con-
ditioning day, full cage-crossovers (mean 6 SEM) were
assessed. Animals that received 1, 10, or 100 mg/kg scopol-
amine, i.p., 15 min earlier showed marked hyperactivity rel-
ative to saline controls (0 mg/kg), whereas those that
received 0.1 or 0.01 mg/kg did not (n 5 14–15/group). (B)
Activity Distribution. The distribution of cage-crossovers
(median 6 range) are depicted. Although 1, 10, and 100 mg/
kg increased average activity, the distribution of activity pri-
marily overlapped; even at 100 mg/kg only two out of 15
animals were outside of the range of that of saline controls.
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to the tone-context compound [F(5,82) 5 47, p , .0001]
or context-alone [F(5,82) 5 32, p , .0001] are evident.
Relative to saline controls, 0.01 mg/kg produced a mild
elevation in freezing for both measures (Fischer’s PLSD,
p , .05), 0.1 produced no significant effects (p . .7) and
1, 10, and 100 mg/kg produced large deficits in post-
shock freezing (p , .0001).
As such, moderate to high doses of scopolamine
readily and robustly disrupted post-shock freezing.
This may have been produced by large increases in mo-
tor activity which may have interfered with post-shock
freezing (Figure 1). In order to address this issue, we
performed an analysis of covariance (ANCOVA) in
which each animal’s activity score was treated as a co-
variate. Even when the variance attributable to differ-
ences in activity was covaried out, significant differ-
ences in both post-shock freezing measures remained
[context-alone, F(1,81) 5 16, p , .0001; compound,
F(1,81) 5 25, p , .0001; significant post-hoc compari-
sons remained as before]. Therefore hyperactivity may
contribute to the deficit in post-shock freezing, but at
most can only partially account for the massive impair-
ment observed. One alternative interpretation is that
post-shock freezing deficits observed on-drug were due
to disruption of short-term working memory processes
that post-shock freezing is thought to depend on (e.g.,
Levin et al. 1990). Indeed, by one view, a working mem-
ory impairment could actually support hyperactivity
by generating abnormal exploratory patterns which
may not show normal habituation (e.g., Maren et al.
1998). Alternatively, both short-term memory impair-
ment and hyperactivity together may have contributed
to this robust and nearly complete impairment.
Additionally, the post-shock freezing data also tend
to suggest that scopolamine’s deficits on later condi-
tioning (tested off-drug) are not due to state-depen-
dency (e.g., Overton, 1966), as the deficits observed on
the drug are substantially greater than those observed
when the rats are tested off drug (see below). The state-
dependency view would likely predict the reverse.
Context Fear.  One week after receiving scopolamine
during training, the animals were returned to the origi-
nal training environment for an off-drug contextual fear
test. Figure 3A depicts the average freezing observed
during the 4-min test. Scopolamine produced dose-
dependent deficits in contextual fear conditioning
[ANOVA, F(5,82) 5 11.4, p , .0001]. Fischer’s PLSD
post-hoc comparisons revealed that, relative to saline
control animals, 1 (p , .05), 10 (p , .001), and 100 (p ,
.0001) mg/kg produced progressively large deficits,
whereas 0.1 and 0.01 mg/kg did not produce signifi-
cant differences (p . .4). Thus scopolamine produced
large deficits in contextual fear, reducing conditioning
by 30–80% at doses of 1–100 mg/kg; however, this was
not as complete as its effect on post-shock freezing,
where high doses abolished freezing altogether.
Tone Fear.  One day after the contextual fear test, ani-
mals were brought to a novel environment, and after a
2-min baseline period, the original training tone was
played for 4 min. Figure 3B depicts the results of this
test. None of the animals exhibited considerable base-
line freezing (data not shown) and the groups did not
differ in this respect [Kruskall-Wallis ANOVA, H(5) 5
3.3, p . .6], but scopolamine did have effects on tone-
elicited freezing [ANOVA, F(5,82) 5 4, p , .01]. Com-
pared to saline controls, 100 mg/kg produced signifi-
cant deficits (p , .01), whereas despite moderate trends
at 1 and 10 mg/kg, these doses did not produce signifi-
cant tone deficits (p . .2). There was some marginal ev-
idence that 1 and 10 mg/kg may have produced a small
deficit in conditioning, as these groups did exhibit sig-
nificantly lower tone fear than 0.01 mg/kg (p , .05),
which did not differ significantly from saline control
animals (p . .6). Nonetheless, tone fear conditioning
appears to be more resistant to scopolamine’s effects
than context conditioning or post-shock freezing.
Median Effective Dose Calculations.  Based on the pre-
ceding findings, it seemed apparent that post-shock
freezing (on drug) was more sensitive to disruption by
Table 1. Pain Sensitivity in Scopolamine-Treated Rats
A. Experiment 1: Shock Reactivity B. Experiment 3: Pain Sensitivity Thresholds
Dose (mg/kg) Baseline (cm/s) Shock (cm/s) Dose (mg/kg) Flinch (mA) Jump (mA) Vocalize (mA)
0 3.7 6 0.3 54.0 6 4.0 0 0.18 6 0.02 0.18 6 0.01 0.18 6 0.01
0.01 3.2 6 0.5 54.0 6 4.1 1 0.34 6 0.05 0.31 6 0.03 0.32 6 0.03
0.1 3.3 6 0.4 53.8 6 3.8 100 0.54 6 0.02 0.52 6 0.04 0.47 6 0.07
1 3.5 6 0.4 55.7 6 3.3
10 3.3 6 0.3 52.0 6 4.8
100 4.0 6 0.3 51.8 6 4.5
Shock reactivity after treatment with scopolamine was assessed according to two protocols. A. Experiment 1: On the conditioning day, the 2-s pe-
riod prior to (baseline) and during the first footshock was digitized by computer and the average velocity (cm/s, mean 6 SEM) was computed for
each drug dose. Doses from 0.01 to 100 mg/kg of scopolamine had no measurable impact on activity burst velocity. B. Experiment 3: Naive rats were
given a series of ascending footshocks until flinch, jump, and vocalize responses were observed. Threshold current (mA, mean 6 SEM) is shown. Sco-
polamine failed to affect pain sensitivity at any dose.
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scopolamine than contextual fear conditioning, which
was in turn more sensitive than tone fear conditioning
(both tested off drug). In order to further compare them
we attempted to calculate median doses for the disrup-
tion of conditioning according to the following proce-
dure derived from Nies (1993): 1) the desired effect was
defined as a one-half reduction in the response relative
to the mean of saline control animals (nontrivial and
also outside the normal variation of controls); as such,
animals in each group that made less than half of the
average control response were assigned a value of 1,
whereas those which made more than this were as-
signed a zero; 2) probability-dose curves were then
generated (Figures 4A-D) and logarithmic curve fits
(excluding saline controls) were made (Kaleida-
graph; Synergy Software); and 3) the ED50s were
computed from the curve fit. In all cases, the curve
fits were quite good, yielding r > 0.95.
Figure 2. (A) Acquisition. During conditioning, post-shock
freezing (% time, mean 6 SEM) was assessed continuously,
while the animals were on the drug. Compared to saline
controls (0 mg/kg), 0.01 mg/kg scopolamine slightly
enhanced post-shock freezing, 0.1 mg/kg had no impact,
and 1 mg/kg produced a substantial deficit (but these ani-
mals still showed significant acquisition). Ten and 100 mg/
kg almost completely blocked post-shock freezing, as over
three-quarters of these animals never froze during training.
(B) Overall Post-Shock Freezing. Overall post-shock freezing
(% time, mean 6 SEM) during conditioning was separated
for periods when the tone was on (context-tone compound)
or not (context alone). Compared to saline controls (0 mg/
kg), 0.01 mg/kg slightly enhanced post-shock freezing dur-
ing either period, 0.1 had no significant impact, whereas 1, 10,
and 100 mg/kg dramatically reduced post-shock freezing.
Figure 3. (A) Context Conditioning. One week after condi-
tioning, the animals were returned to the original training
context, off drug, and freezing (% time, mean 6 SEM) was
scored for 4 min. Compared to saline controls (0 mg/kg), 1,
10, and 100 mg/kg significantly attenuated conditioning,
whereas 0.01 and 0.1 mg/kg did not. (B) Tone Conditioning.
On the next day, the animals were brought to a novel con-
text and freezing (% time, mean 6 SEM) during the 4-min
tone is depicted. Relative to controls, only 100 mg/kg signif-
icantly impaired tone conditioning, modest trends were evi-
dent at 1 and 10 mg/kg. As such, tone conditioning is more
resistant to disruption by scopolamine than context condi-
tioning, which is in turn more resistant than post-shock
freezing (Figure 2).
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Figures 4A-B depict the probability of observing a
one-half decrement in post-shock freezing relative to
dose. Comparable, and low doses of scopolamine (0.7–
0.8 mg/kg) were required to attenuate post-shock
freezing to either the context or context-tone compound
in half the animals. The similar slopes and intercepts
suggest these are mediated by the same effect of the
drug. These observations are also in good agreement
with the results from the ANOVAs, where doses of 1, 10,
and 100 mg/kg produced large and significant deficits.
Figure 4. Experiment 1: Summary / Median Effective Dose. For each response, probabilities of obtaining a one-half reduc-
tion in conditioning (relative to the mean of saline controls) was calculated for each dose; after a logarithmic curve fit was
made, median doses for each effect were calculated. (A) Post-Shock Freezing, Context-Alone. Both 10 and 100 mg/kg were
sufficient to reduce post-shock freezing (taken while the animal was on-drug, during conditioning) in nearly all of the ani-
mals, whereas even 1 mg/kg had this effect in over two-thirds of the animals. The obtained curve fit (r 5 0.95) was y 5 0.55 1
0.30log(x), ED50 5 0.8 mg/kg. (B) Post-Shock Freezing, Compound. The results were substantially similar to context-alone
post-shock freezing indicating these are probably the same effect of the drug. The obtained (r 5 0.96) was y 5 0.52 1
0.29log(x), ED50 5 0.7 mg/kg. (C) Context Conditioning. When the animals were tested off-drug one week later, the drug
appeared to disrupt context conditioning considerably less. In contrast to post-shock freezing, even 100 mg/kg was not suf-
ficient to disrupt conditioning in all of the animals, and 1 mg/kg reduced conditioning by half in only about one-third of the
animals. The obtained curve fit (r 5 0.98) was y 5 0.40 1 0.24log(x), ED50 5 2.7 mg/kg. (D) Tone Conditioning. Tone condi-
tioning (tested off drug, nine days after conditioning) was even more resistant to disruption by scopolamine. Only 100 mg/
kg was sufficient to reduce the response by one-half and only in about 55% of the animals. The obtained curve fit (r 5 0.95)
was y 5 0.29 1 0.14log(x), ED50 5 38.5 mg/kg. As such, tone conditioning, context conditioning, and post-shock freezing are
all susceptible to anticholinergic disruption, however, they are differentially sensitive to the drug such that the disruption is
post-shock . context . tone.
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Figures 4C and D depict the dose-effect curve for the
disruption of contextual and tone fear conditioning. For
context, about 2.7 mg/kg was required to reduce freez-
ing in half in one-half of the animals, whereas for tone a
much higher dose, 38.5 mg/kg, was required. Again,
this agreed with the ANOVAs, where contextual fear
was sensitive in the range of 1–100 mg/kg, whereas sig-
nificant deficits in tone fear were only observed at a
dose of 100 mg/kg. Thus, post-shock freezing (on drug)
is more scopolamine-sensitive than contextual fear con-
ditioning, which is in turn more sensitive than tone fear
conditioning (both tested off drug). The dissimilar
slopes for postshock freezing, context, and tone fear
suggest these are dissociable actions of the drug.
Finally, although changing the definition of the de-
sired effect (for example, to a one-third or two-thirds
deficit) alters the ED50s (lowering or raising them), it
does not affect their relative positions (data not shown);
that is, the deficits are always aligned such that post-
shock freezing . context conditioning . tone condi-
tioning.
Experiment 2: The Effect of Pre-Training 
Methylscopolamine on Fear Conditioning
Figures 5A-C Depict the effects of pre-training meth-
ylscopolamine on generalized activity, contextual fear,
and tone fear conditioning. In contrast to scopolamine,
1 or 10 mg/kg of methylscopolamine did not produce
an increase in cage cross-overs during training relative
to saline-treated controls [on drug; F(2,26) 5 0.3, p . .7],
nor did it produce deficits in contextual or tone fear
conditioning measured off-drug one week later [con-
text, F(2,26) 5 0.3, p . .7; tone, F(2,26) , 0.2, p . .8].
This suggests that the effects observed in Experiment 1
were due to the central rather than peripheral action of
scopolamine.
Experiment 3: Scopolamine and
Shock-Intensity Thresholds
For further validation of the novel UR measure used in
Experiment.1, a naive set of animals were given 0, 1, or
100 mg/kg scopolamine and then their thresholds to
show stereotypical progressive flinch, jump, and vocal-
ization responses were recorded. Consistent with our
activity burst results (Table 1A, Experiment 1), Table 1B
(Experiment 3) shows that scopolamine failed to affect
shock reactivity for any response at any dose, although
a very modest trend toward elevated vocalization reac-
tivity is evident. Separate univariate ANOVAs for each
response confirmed the general appearance of the num-
bers [flinch, F(2,15) 5 0.4, p . .6; jump, F(2,15) 5 0.2,
p . .8; vocalize, F(2,15) 5 0.4, p . .6].
In the present study and in Experiment 1, scopola-
mine failed to produce any detectable effect on pain
sensitivity as measured by the animal’s visible reaction
to the shock during conditioning (Table 1A) or by
flinch-jump-vocalization thresholds (Table 1B). This is
in some disagreement with the findings of Grau et al.
Figure 5. Experiment 2: Pretraining Methylscopolamine and Fear Conditioning. (A) Activity. Animals which received 0, 1,
or 10 mg/kg (n 5 9–10/group) methylscopolamine, i.p., 15-min prior to conditioning were scored for full-cage crossovers
(mean 6 SEM) during the 3-min baseline period prior to the first tone-shock pairing. Methylscopolamine treated animals
showed no evidence of hyperactivity, in contrast to those treated with scopolamine (Figure 1). (B) Context Conditioning.
One week after training, the animals were returned to the original training context for a 4-min contextual freezing (mean 6
SEM) test. Animals which received methylscopolamine on the training day did not differ from saline controls. (C) Tone Con-
ditioning. One day after the context test, the animals were tested for freezing (mean 6 SEM) to a 4-min tone in a novel con-
text. Methylscopolamine treated animals did not differ from saline controls. As such, all of the effects observed in
Experiment 1 appear to be mediated by the central, rather than peripheral effects of scopolamine.
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(1991) who found hyperalgesia evidenced by reduced
vocalization thresholds (albeit with a different shock
source) and reduced tail-flick latencies at 1 mg/kg of
scopolamine. Thus, depending on experimental condi-
tions, scopolamine seems to produce no effect on pain
sensitivity, as we observed (also Houser & Hart, 1973),
or hyperalgesia as others have observed (Grau et al.,
1991; Watkins et al., 1984). In either case, the amnesic ef-
fects of scopolamine on learning cannot be attributed to
decreased sensitivity to shock.
Experiment 4: Post-Training Scopolamine and 
Fear Conditioning
Because we have previously failed to observe any defi-
cit in conditioning from 1 mg/kg of scopolamine given
immediately (and for two more days) after training
(Anagnostaras et al. 1995), we examined the effect of a
much higher dose, 10 mg/kg, given post-training. Fig-
ures 6A-B show that even this dose failed to produce
any deficit in conditioning in adult rats. Separate
univarate ANOVAs confirmed this observation for
context [F(2,26) 5 0.2, p . .8] and tone conditioning
[F(2,26) 5 0.3, p . .7].
The lack of retrograde amnesia from even 10 mg/kg
of immediate post-training scopolamine is in some dis-
parity with the findings of Rudy (1996), who found that
one-tenth of this dose readily disrupted consolidation
in 23-day-old rats. As such, Experiment 5 sought to de-
termine if this effect was unique to immature rats.
Experiment 5: Post-Training Scopolamine and Fear 
Conditioning in Juvenile and Mature Rats
In Experiment 5, we examined the effect of 1 or 50 mg/
kg of immediate post-training scopolamine under re-
duced fear conditioning (relative to Experiments 1, 2,
and 4) in 23-day-old (Juvenile) and 70-day-old (Mature)
rats. It is obvious from examination of Figures 7A and
7B that scopolamine failed to produce retrograde amne-
sia of context or tone fear at 1 or 50 mg/kg. This was
confirmed by separate 2 3 3 (age 3 dose) ANOVAs for
context and tone conditioning. There was no age 3
dose interaction for either context or tone fear [F (2,66) ,
0.3, p . .7].
There was no main effect of drug dose for either
measure [F (2,66) , 0.7, p . .5] nor any significant post-
hoc comparisons between drug dose groups within
each age for either response (p . .5). There was, how-
ever, a main effect of age, as Juvenile animals froze sig-
nificantly more than Mature animals to either the con-
text [F(1,66) 5 18, p , .0001] or tone [F(1,66) 5 14, p ,
.001]. However, this was at least partially accounted for
by higher baseline freezing, which averaged 13.6 6
3.7% in Juvenile rats and 0.3 6 0.2% in Mature
rats[F(1,70) 5 14, p , .001]; baseline freezing was unaf-
fected by and did not interact with drug dose [F (2,66) ,
1.2, p . .3]. As such, despite differences in the absolute
amount of freezing observed in Juvenile and Mature ani-
mals (which may have many sources), it is clear that
post-training scopolamine, even at doses of 50 mg/kg
did not produce retrograde amnesia in Juvenile or Ma-
ture for context or tone fear conditioning.
It is unclear why we did not observe retrograde am-
nesia reported by Rudy (1996) with post-training i.p. in-
jections of scopolamine. He observed an amnesia of
contextual fear, under similar parameters, even when 1
mg/kg, s.c., was given up to 3 hrs after training. It is
clear that this difference was not simply due to the fact
Figure 6. Experiment 4: Post-Training Scopolamine and
Fear Conditioning. In order to assess the effect of posttrain-
ing scopolamine, animals received either saline (Control) or
10 mg/kg scopolamine either immediately (Immediate) or 24
hrs after (Delay) conditioning (n 5 9–10/group). (A) Context
Conditioning. One week after training, the animals were
given a 4-min contextual freezing (mean 6 SEM) test. Rats
treated with 10 mg/kg post-training scopolamine did not
differ from saline controls. (B) Tone Conditioning. On the
next day, animals were tested for their freezing (mean 6
SEM) to a 4-min tone. Rats treated with post-training scopol-
amine did not differ from controls. As such, although 10
mg/kg of pre-training scopolamine severely disrupted con-
ditioning (Figure 3), the same dose of post-training scopol-
amine had virtually no effect.
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that he used 23-day-old rats, as we previously sug-
gested (Anagnostaras et al. 1995). One possibility is that
the level of fear in the present study was higher than in
Rudy (1996) and that low levels of fear are more suscep-
tible to post-training scopolamine (indeed, in Rudy’s
work, one training trial was more susceptible than 3
training trials). Another possibility is that s.c. scopol-
amine used by Rudy (1996) may have been active
longer than the i.p. scopolamine we used, but this
seems unlikely, as our high dose was fifty times higher.
In any case, it is clear that anterograde amnesia induced
by scopolamine is more robust and more readily ob-
servable than retrograde amnesia, at least under the
high levels of fear used in the present studies (see also
Rudy, 1996, Experiment 5). This is consistent with ex-
aminations of scopolamine’s effects in a variety of other
tasks, where amnesic effects from post-training scopo-
lamine are not as consistently observed as the pervasive
effects of pre-training administration (e.g., Aigner et al.
1991; Hagan et al. 1986)
DISCUSSION
At the behavioral level, Pavlovian fear conditioning in-
volves the association of two types of conditional stim-
uli (the tone and context) with an aversive uncondi-
tional stimulus (US). Scopolamine might produce
deficits in several fundamental processes: during condi-
tioning, scopolamine could disrupt the animal’s ability
to process the US, to process the contextual and tone
CSs, or to associate the CSs and US together. After
training, scopolamine could disrupt the consolidation
of the internalized memories of the US or CSs (i.e., the
representations) or of the CS-US association. Based on
the present data, it does not appear that scopolamine
disrupts US processing or consolidation (c.f., Rudy,
1996) (see below), but pre-training scopolamine may at-
tenuate the rat’s ability to process the CSs or to associ-
ate them with the shock.
Scopolamine Compared with Hippocampal Lesions
It is sometimes claimed that the effects of anticholin-
ergic action mimic those observed after hippocampal
lesions (Watts et al. 1981). Moderate pre-training doses
produce motor hyperactivity (Figure 1), attenuate post-
shock freezing (Figure 2), and produce robust and rela-
tively selective deficits in contextual fear (Figures 3 and
4), much in the way hippocampal lesions do (Maren
and Fanselow 1997; Phillips and LeDoux 1992). In con-
trast, post-training scopolamine had no impact on con-
solidation in the present study even when given at very
high doses. Although post-training scopolamine may
produce deficits under low levels of fear, a severe retro-
grade amnesia of contextual fear results from hippo-
campal lesions even after intensive training (Kim and
Fanselow 1992; Anagnostaras et al. 1999). Even in
Rudy’s (1996) study, post-training scopolamine pro-
duced deficits when given up to 3 hrs, but not 24 hrs af-
Figure 7. Experiment 5: Post Training Scopolamine and
Fear Conditioning in Juvenile and Mature Rats. In order to
determine if the apparent discrepancy with the findings of
Rudy (1996) was due to his use of 23-day-old rats, we exam-
ined the effect of 1 and 50 mg/kg of immediate post-training
scopolamine in 23-day-old (Juvenile) and 70-day-old (Mature)
rats (n 5 11–13/cell). (A) Context Conditioning. One week
after training, the animals were given a 4-min contextual
freezing test (mean 6 SEM). Although Juvenile rats froze sig-
nificantly more than Mature rats, there was no significant
impact of 1 or 50 mg/kg of post-training scopolamine on
contextual fear in Juvenile or Mature rats. (B) Tone Condition-
ing. On the next day, animals were tested for their freezing to
a 4-min tone. Juvenile rats again froze more than Mature rats,
but this was apparently due to higher baseline freezing (data
not shown). Neither 1 nor 50 mg/kg of post-training scopola-
mine produced a significant deficit in tone fear in Juvenile or
Mature rats. As such, under the conditions in the present
studies, we could not obtain post-training effects of scopol-
amine even at very high doses (50 mg/kg) given immedi-
ately after training, even in very young rats. We are not able
to account for this discrepancy with Rudy (1996), although
his findings indicate there are some conditions under which
post-training scopolamine produces retrograde amnesia.
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ter training. In contrast, hippocampal lesions made
even 1 wk after training produce substantial deficits
(Kim and Fanselow 1992; Maren et al. 1997).
Indeed, deficits observed when hippocampal lesions
are made post-training are usually greater than those
given pre-training (Maren et al. 1997, 1998), whereas the
opposite appears to be true of scopolamine. As such, pre-
training scopolamine (at moderate doses) seems to
mimic the effects of hippocampal lesions, whereas post-
training scopolamine (at any dose) does not.
Scopolamine Compared with Amygdala Lesions
One possibility is that some of scopolamine’s effects
may be due to disruption of the amygdala. Lesions di-
rected at the amygdala produce a severe anterograde
amnesia of contextual and tone fear (Phillips and
LeDoux 1992), as well as a severe, temporally-stable ret-
rograde amnesia of both types of conditioning (Maren
et al. 1996a). As such, scopolamine did not nearly have
as great an effect as do lesions of the amygdala, even at
50–100 mg/kg. Nonetheless, because of effects on tone
conditioning, some scopolamine deficits may be
through action in the amygdala, but this is not equiva-
lent to amygdalar destruction.
Scopolamine Compared with NMDA
Receptor Antagonism
Pre-training, but not post-training administration of
APV, which blocks the induction (but not expression) of
LTP (Collingridge et al. 1983), blocks Pavlovian fear
conditioning. Pre-training intra-cerebral, intra-hippo-
campal, or intra-amygdalar infusion of APV blocks con-
textual fear, whereas post-training administration does
not (Kim et al. 1991; Fanselow et al. 1994; Young et al.
1994; Maren et al. 1996b; Kim et al. 1992; Campeau et al.
1992). Thus, the effects of scopolamine appear to be
similar the effects of the NMDA receptor antagonist
APV. These observations are consistent with the view
that scopolamine may be disrupting acquisition pro-
cesses similar to those for which NMDA receptor acti-
vation (and LTP) is required.
Scopolamine and LTP
Because it has been observed that LTP can be optimally
induced in the hippocampus when presynaptic high
frequency bursts are delivered at theta rhythm (Larson
et al. 1986), there has been considerable speculation that
cholinergic modulation of theta rhythm may be impor-
tant to the induction of LTP (Huerta and Lisman 1995).
Studies examining the role of scopolamine on LTP are
somewhat mixed but cholinergic activation may be im-
portant under conditions of minimal or natural stimula-
tion. Under stimulation that mimicked naturally occur-
ring bursts in the hippocampus, Huerta and Lisman
(1995) found an LTP that was blocked by either scopol-
amine or APV. Some have speculated that cholinergic
activation of theta rhythm may enable LTP induction in
concert with the activation of exploratory behavior, as
these logically accompany one another (Buszáki and
Gage 1991). Thus, it is possible that cholinergic neu-
rotransmission plays a similar or complementary role
to NMDA receptor transmission in the acquisition pro-
cesses.
Scopolamine and CS Processing
Because scopolamine’s effects were restricted to when
the drug was given before training, one possibility is
that scopolamine disrupts the acquisition of Pavlovian
fear by disrupting the animal’s ability to process,
through sensory-perceptual disturbance, the context
and tone cues that were paired with shock (e.g., Whishaw
and Tomie 1987). Context conditioning may have been
more sensitive to cholinergic disruption than tone con-
ditioning, because contextual fear conditioning requires
the integration of multiple sensory cues (i.e., visual,
acoustic, olfactory, etc.) whereas tone conditioning re-
quires the sampling of only one cue (e.g., Kim and
Fanselow 1992; Rudy 1996; Anagnostaras et al. 1995).
This is still somewhat similar to the role we have pro-
posed for the hippocampus in contextual fear condi-
tioning, which we have argued forms the contextual CS
by assembling multiple cues into a single spatial or con-
figural representation (Kim and Fanselow 1992; Young
et al. 1994; Maren et al. 1998; Frankland et al. 1998;
Anagnostaras et al. 1999). Nonetheless, ruling out the
less exciting possibility that scopolamine produced def-
icits through purely sensory disturbance will require
further investigation.
CONCLUSIONS
As such, the hippocampus, which mediates contextual
conditioning, may be more readily impacted by scopol-
amine than the amygdala, which mediates fear more
generally. At moderate doses, scopolamine produced
effects somewhat similar to NMDA receptor antago-
nism, suggesting muscarinic neurotransmission may
play a complementary role in the acquisition processes.
Systemic scopolamine may have acted in the hippocam-
pus to robustly disrupt contextual fear conditioning,
and in the amygdala to attenuate tone conditioning at
high doses. Because the drug was given systemically,
many other interpretations are possible and studies are
in progress examining the effects of site-specific admin-
istration of scopolamine. In preliminary studies exam-
ining local pre-training administration of scopolamine
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to the hippocampus we have found a disruption of con-
text, but not tone conditioning (Gale et al. 1998).
Finally, the present findings further bind together
contextual fear conditioning the hidden-platform Mor-
ris water maze and “win-shift” radial maze learning in
rats. All three tasks are disrupted by lesions of the hip-
pocampus or NDMA receptor antagonism (Kim and
Fanselow 1992; Anagnostaras et al. 1999; Kim et al.
1991; Morris et al. 1986; Kawabe et al. 1998) all three ex-
hibit sexual dimorphism (Maren et al. 1994b; Anagnost-
aras et al. 1998; Williams and Meck 1991), and recent
evidence indicates similar targeted mutations in mice
disrupt these tasks (e.g., Lu et al. 1997). The present re-
port confirms that contextual fear conditioning, like the
water (Hagan et al. 1986) and radial (Levin et al. 1990)
mazes, is also sensitive to cholinergic disruption. While
the relative sensitivity to scopolamine of the hippocam-
pal dependent and independent versions of these tasks
remains in considerable dispute (e.g., Hagan et al. 1986),
there is at least some consensus that the hippocampal
versions are more sensitive. Thus, although these tasks
are very different in nature, they seem to be served by
common mechanisms.
In summary, scopolamine dose-dependently dis-
rupted the acquisition, but not the consolidation, of
contextual fear conditioning, a hippocampal-dependent
form of learning. The effects were somewhat similar to
NMDA receptor antagonism, suggesting that cholin-
ergic neurotransmission plays a similar or complemen-
tary role in the acquisition processes. Further study is
necessary to determine the loci of scopolamine’s effects
and the exact conditions under which post-training sco-
polamine may produce retrograde amnesia.
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